{"id":33084,"date":"2025-03-05T07:15:00","date_gmt":"2025-03-05T07:15:00","guid":{"rendered":"https:\/\/g-medtech.com\/news\/?p=33084"},"modified":"2025-08-21T15:05:48","modified_gmt":"2025-08-21T15:05:48","slug":"nervonik-raises-13-million-to-advance-next-generation-peripheral-nerve-stimulation-for-chronic-pain-relief","status":"publish","type":"post","link":"https:\/\/g-medtech.com\/news\/nervonik-raises-13-million-to-advance-next-generation-peripheral-nerve-stimulation-for-chronic-pain-relief\/","title":{"rendered":"Nervonik Raises $13 Million to Advance Next-Generation Peripheral Nerve Stimulation for Chronic Pain Relief"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\">California-based <a href=\"https:\/\/g-medtech.com\/database\/medtech-players\/index\/nervonik\/\" target=\"_blank\" rel=\"noreferrer noopener\">Nervonik<\/a> has closed a $13 million Series A funding round led by <a href=\"https:\/\/g-medtech.com\/database\/medtech-players\/index\/usvp\/\" target=\"_blank\" rel=\"noreferrer noopener\">U.S. Venture Partners (USVP)<\/a>, with participation from Foothill Ventures, Correlation Ventures, and other investors. The funding will advance clinical studies, accelerate regulatory clearance, and prepare for commercialization efforts aimed at transforming chronic pain treatment.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">This funding builds on Nervonik\u2019s earlier $4.4 million in SAFE and convertible note financings from Shangbay Capital, Camford Capital, Joyance Partners, Life Science Angels, Seraph Group, and other investors.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Nervonik recently completed its first-in-human clinical study, demonstrating the potential of its peripheral nerve stimulation (PNS) technology to transform chronic pain treatment. The company\u2019s proprietary wirelessly powered PNS technology delivers minimally invasive, patient-friendly therapy for personalized pain relief. With chronic pain affecting over 50 million people in the U.S. alone, Nervonik\u2019s opioid-free PNS technology offers a compelling alternative to traditional pain management methods, targeting a multibillion-dollar market opportunity.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">\u201cWe are excited to receive this strong support from top institutional investors as we push forward in advancing peripheral nerve stimulation technology,\u201d said Aydin Babakhani, PhD, founder and CEO of Nervonik. \u201cThis financing advances our mission to bring a novel solution to millions of people suffering from chronic pain.\u201d<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Nervonik has closed a $13 million Series A funding round to advance its opioid-free peripheral nerve stimulation (PNS) technology, offering a transformative solution for chronic pain relief.<\/p>\n","protected":false},"author":2,"featured_media":33085,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"colormag_page_layout":"default_layout","footnotes":""},"categories":[488,681,10],"tags":[594],"class_list":["post-33084","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-breaking-news","category-care-therapy","category-strategic-development","tag-financing"],"_links":{"self":[{"href":"https:\/\/g-medtech.com\/news\/wp-json\/wp\/v2\/posts\/33084","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/g-medtech.com\/news\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/g-medtech.com\/news\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/g-medtech.com\/news\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/g-medtech.com\/news\/wp-json\/wp\/v2\/comments?post=33084"}],"version-history":[{"count":4,"href":"https:\/\/g-medtech.com\/news\/wp-json\/wp\/v2\/posts\/33084\/revisions"}],"predecessor-version":[{"id":34763,"href":"https:\/\/g-medtech.com\/news\/wp-json\/wp\/v2\/posts\/33084\/revisions\/34763"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/g-medtech.com\/news\/wp-json\/wp\/v2\/media\/33085"}],"wp:attachment":[{"href":"https:\/\/g-medtech.com\/news\/wp-json\/wp\/v2\/media?parent=33084"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/g-medtech.com\/news\/wp-json\/wp\/v2\/categories?post=33084"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/g-medtech.com\/news\/wp-json\/wp\/v2\/tags?post=33084"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}